Clinical Report: Beyond Body Mass Index: Exploring Frailty and Central Adiposity Phenotypes
Background
The aging population is expected to increase the burden of critical illness, necessitating accurate prognostication tools. While BMI is widely used for assessing body size and composition, its prognostic value is limited, particularly in distinguishing between different physiological profiles. Frailty, characterized by a decline in functional reserve, is associated with poorer outcomes and can be assessed without complex investigations, making it a valuable tool in critical care.
Data Highlights
No numerical or trial data available in the source material.
Key Findings
BMI has a J-shaped association with mortality, with nadir risk at BMI 21–24.9 kg/m2.
Frailty, measured by the Clinical Frailty Scale (CFS), is linked to poorer outcomes in critical illness.
Combining BMI and frailty may improve prognostication in ICU patients.
Patients with sarcopenic obesity represent a high-risk group with poorer outcomes.
A recent study found a U-shaped relationship between BMI and frailty, with frailty most prevalent at BMI extremes.
Clinical Implications
Clinicians should consider both BMI and frailty assessments when evaluating critically ill patients.
Conclusion
Integrating frailty assessments with BMI may enhance the understanding of patient risk profiles in critical care.
